Kestra Medical Technologies, LTD DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Kestra Medical Technologies, Ltd. is holding its 2026 Annual General Meeting of Shareholders virtually on September 9, 2026, to elect directors and ratify auditor appointment.
NASDAQ
Kestra Medical Technologies, Ltd. has announced its 2025 Annual Meeting of Shareholders for September 3, 2025, to vote on director elections, auditor ratification, and an employee stock purchase plan.
NASDAQ
Kestra Medical Technologies, Ltd. announced its 2025 Annual General Meeting of Shareholders to be held virtually on September 3, 2025, to vote on director elections, auditor ratification, and a new employee stock purchase plan.